[Business Wire] - CAMBRIDGE, Mass.----Helicos BioSciences Corporation announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for patent infringement. The lawsuit, filed in the United States District Court for the District of Delaware, accuses PacBio of infringing four patents and seeks injunctive relief and monetary damages.
[Business Wire] - CAMBRIDGE, Mass.----Helicos BioSciences Corporation today announced a publication demonstrating the detection and quantification of novel small RNA molecules using Helicos? single-molecule sequencing technology.
[Business Wire] - CAMBRIDGE, Mass.----Helicos BioSciences Corporation today announced a publication entitled ?Amplification-free digital gene expression profiling from minute cell quantities? appearing on line in Nature Methods co-authored by Dr.
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for patent infringement. The lawsuit, filed in the United 2010 09 08 16:30
Helicos BioSciences Corporation (NASDAQ: HLCS) today announced a publication demonstrating the detection and quantification of novel small RNA molecules using Helicos? single-molecule sequencing 2010 07 29 16:30
Helicos BioSciences Corporation (NASDAQ: HLCS) today announced a publication entitled ?Amplification-free digital gene expression profiling from minute cell quantities? appearing on line in Nature 2010 07 20 07:30
Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it is in the early stages of validating molecular diagnostic (MDx) tests that utilize its HeliScopeŽ Single Molecule Sequencer. 2010 06 25 07:00
Record losses at two of the world’s largest and most venerable airlines, British Airways andAir-France-KLM, pushed them onto Alacra Pulse’s top 10 ranking of companies under pressure this week. As if things weren’t bad enough for BA, after suffering extensive flight cancellations due to volcanic ash, the courts just cleared the way for another round of cabin crew strikes in the run-up to the World Cup soccer finals in South Africa.
Big Pharma companies often seem to be resistant to bad news, but that didn’t keep
Roche (RHHBY.PK) and Biogen Idec (BIIB) say they will discontinue development of late-stage ocrelizumab in rheumatoid arthritis. The decision follows an analysis of the efficacy and safety results from the program that led the companies to conclude the antibody carried too great a risk to rheumatoid arthritis patients compared to benefits and available treatment options. The ocrelizumab rheumatoid arthritis program included four late-stage studies. Ocrelizumab is also being evaluated for relapsing remitting multiple sclerosis in a mid-stage trial. In...
The cost of sequencing a human genome has fallen below $10,000 for the first time, a feat which has the potential to transform research costs and, eventually, therapeutic strategies. The new sequencers, made by San Diego-based Illumina (ILMN), up the ante in an ever-quickening race between Illumina and its competitors, such as Life Technologies (LIFE), Helicos (HLCS) and Pacific Biosciences, to knock down the cost of whole-genome sequencing while improving speed and ease of use.
A Beijing genomics institute, BGI is purchasing 128 of the new HiSeq 2000 sequencing systems to aid $1.5 billion of research...
In Q3 2009, life science and biotech stocks kept pace with market sectors that offer comparable risk and performance such as small-cap growth, science and technology, and midcap growth.
The Rayno Report (raynoreport), in conjunction with our contributing partner Raygent Associates (raygentassociates), tracks the biotech market and a model portfolio. The broadly diversified biotech ETF -- IBB -- was up 16%, moving from 70 to 81 in the three-month period. About 50% of the IBB holdings are large cap companies such as Amgen (
It all comes down to capital and how to get it—through the public markets, VCs, or dealmaking. This week three companies raised the possibility that the biotech IPO window might be cracking open. First private equity owned Talecris (TLCR) took its show on the road, offering an initial 44.7 million shares priced at $18 to $20. If successful, the IPO could generate $850 million for Talecris and its major shareholder, Cerberus Partners.
Talecris was spun out of Bayer in 2005 and filed for a $1 billion IPO in 2007, which was scuttled when Australian...
In this post is a list of 13 stocks that I'll be keeping an eye on for the week ahead. All of the stocks mentioned in this post are stocks that have broken out to the upside on unusually large volume. The table below shows the company, ticker, Friday's per share % increase, and Friday's volume increase (% increased compared to 50 day average).
Below is a summary of sector performance for the week of August 10-14th. Healthcare was the best performer, and given some of the weekend news developments with the potential 'watering-down' of the healthcare initiative, we could continue to see outperformance in that sector. The best performing stock (with a $1 minimum share price) is also listed for each sector.
Following my post last month Helicos Part III: To Buy or Not to Buy?, I had an opportunity to interview the Chief Operating Officer and Executive Vice President of Helicos BioSciences Corp. (HLCS), Steve Lombardi. It was a very informative conversation from both a scientific and investor standpoint, and I'd like to take the time to cross post some especially exciting excerpts. The complete transcript of the interview, as well as the background research on Helicos can be found here.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (NASDAQ: HLCS) announced today that it has filed a lawsuit against Pacific Biosciences of California, Inc. for patent ...
By Chip Brian Below are the top five most inefficient companies in the Life Sciences Tools & Services industry as ranked by Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the ...
By Chip Brian Below are the top five companies in the Life Sciences Tools & Services industry as measured by beta. Higher-beta stocks mean greater volatility and are therefore generally considered ...
By Chip Brian Below are the top five companies in the Life Sciences Tools & Services industry as measured by beta. Higher-beta stocks mean greater volatility and are therefore generally considered ...
By Chip Brian SmarTrend's candlestick pattern scanner has detected a potential bearish harami candle pattern for shares of Helicos BioSciences (NASDAQ:HLCS). Today's real body is within yesterday ...
NuEarth Corp. (NUEC.PK) is a company dedicated to bringing to market ?Clean Solutions to Complex Problems? by offering a wide range of degradable, environmentally friendly products and ...
EpiCept Corporation (NASDAQ:EPCT) shares were down 41.29% by mid-day trading Monday on volume of over 982,000 shares traded, almost 10 times it's average daily volume of 93,000 shares traded. Jazz ...
By Chip Brian Helicos BioSciences (NASDAQ:HLCS) traded in a range yesterday that spanned from a low of $0.56 to a high of $0.67. Yesterday's low of the day pierced the 3-day low of $0.63 on volume ...
By Chip Brian Below are the top five most inefficient companies in the Life Sciences Tools & Services industry as ranked by Revenue Per Employee (RPE). Analysts use RPE as a measure to compare the ...
Stock News 
